Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 9 studies | 24% ± 6% | |
macrophage | 6 studies | 33% ± 8% | |
myeloid cell | 3 studies | 20% ± 3% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 25% ± 5% | |
alveolar macrophage | 3 studies | 28% ± 5% |
Insufficient scRNA-seq data for expression of TEC at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 294.17 | 653 / 653 | 99% | 5.66 | 597 / 605 |
kidney | 100% | 241.71 | 89 / 89 | 98% | 3.38 | 883 / 901 |
intestine | 99% | 245.23 | 957 / 966 | 98% | 3.45 | 514 / 527 |
lung | 100% | 454.98 | 578 / 578 | 94% | 3.73 | 1086 / 1155 |
prostate | 99% | 159.18 | 243 / 245 | 95% | 2.22 | 476 / 502 |
bladder | 100% | 221.00 | 21 / 21 | 90% | 2.68 | 456 / 504 |
stomach | 95% | 123.56 | 341 / 359 | 95% | 3.15 | 272 / 286 |
esophagus | 99% | 417.54 | 1428 / 1445 | 89% | 2.76 | 163 / 183 |
uterus | 100% | 183.48 | 170 / 170 | 88% | 3.00 | 402 / 459 |
breast | 99% | 224.20 | 456 / 459 | 86% | 2.00 | 967 / 1118 |
pancreas | 87% | 101.97 | 286 / 328 | 96% | 3.10 | 171 / 178 |
ovary | 83% | 105.14 | 150 / 180 | 100% | 7.41 | 428 / 430 |
liver | 100% | 271.93 | 226 / 226 | 62% | 1.57 | 250 / 406 |
skin | 82% | 567.72 | 1486 / 1809 | 79% | 2.60 | 374 / 472 |
adrenal gland | 100% | 367.98 | 258 / 258 | 51% | 1.88 | 117 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.75 | 29 / 29 |
spleen | 100% | 380.11 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 240.27 | 1195 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 210.12 | 1314 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 931.07 | 849 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 2.33 | 38 / 45 |
heart | 84% | 119.92 | 722 / 861 | 0% | 0 | 0 / 0 |
muscle | 67% | 71.10 | 542 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 40% | 0.72 | 32 / 80 |
brain | 7% | 6.12 | 184 / 2642 | 6% | 0.12 | 44 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0006468 | Biological process | protein phosphorylation |
GO_0010543 | Biological process | regulation of platelet activation |
GO_0042246 | Biological process | tissue regeneration |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005543 | Molecular function | phospholipid binding |
Gene name | TEC |
Protein name | Tec protein tyrosine kinase Tyrosine-protein kinase Tec (EC 2.7.10.2) |
Synonyms | PSCTK4 |
Description | FUNCTION: Non-receptor tyrosine kinase that contributes to signaling from many receptors and participates as a signal transducer in multiple downstream pathways, including regulation of the actin cytoskeleton. Plays a redundant role to ITK in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. Required for TCR-dependent IL2 gene induction. Phosphorylates DOK1, one CD28-specific substrate, and contributes to CD28-signaling. Mediates signals that negatively regulate IL2RA expression induced by TCR cross-linking. Plays a redundant role to BTK in BCR-signaling for B-cell development and activation, especially by phosphorylating STAP1, a BCR-signaling protein. Required in mast cells for efficient cytokine production. Involved in both growth and differentiation mechanisms of myeloid cells through activation by the granulocyte colony-stimulating factor CSF3, a critical cytokine to promoting the growth, differentiation, and functional activation of myeloid cells. Participates in platelet signaling downstream of integrin activation. Cooperates with JAK2 through reciprocal phosphorylation to mediate cytokine-driven activation of FOS transcription. GRB10, a negative modifier of the FOS activation pathway, is another substrate of TEC. TEC is involved in G protein-coupled receptor- and integrin-mediated signalings in blood platelets. Plays a role in hepatocyte proliferation and liver regeneration and is involved in HGF-induced ERK signaling pathway. TEC regulates also FGF2 unconventional secretion (endoplasmic reticulum (ER)/Golgi-independent mechanism) under various physiological conditions through phosphorylation of FGF2 'Tyr-215'. May also be involved in the regulation of osteoclast differentiation. . |
Accessions | D6RB05 ENST00000515146.1 ENST00000505452.5 P42680 ENST00000381501.8 D6RB75 |